Mandate

Vinge advises Geveko in connection with its new share issue

February 25, 2010

AB Geveko (publ) has resolved to carry out a new share issue with preferential rights for the shareholders. Through the new issue, which is fully committed and underwritten, the company will raise approximately SEK 160 million excluding transaction costs. The new issue is subject to approval by the extraordinary shareholders’ meeting on 31 March 2010.

AB Geveko is listed on NASDAQ OMX Stockholm.

Vinge’s team consisted primarily of responsible partner Göran Nyström and the associates Anna Björk Larson and Emil Hedberg.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025